John E Emma

Title: John E Emma: Innovator in Triarylphosphinimide Derivatives

Introduction

John E Emma is a notable inventor based in Rockland, NY (US), recognized for his contributions to the field of chemistry. He holds a total of 2 patents, showcasing his innovative approach to developing novel compounds.

Latest Patents

His latest patents include significant advancements in certain triphenylphosphinimide derivatives. These derivatives are characterized by their unique formula, where R1, R2, and R3 are positioned at the ortho or meta locations, representing mono- or disubstituents selected from hydrogen, alkyl (C1-C3), alkoxy (C1-C3), trifluoromethyl, and halogen. Additionally, R4 is chosen from a diverse group of substituents, including various alkyl and cycloalkyl groups, which contribute to their functionality in medical applications. These compounds are designed to effect diuresis, lower plasma renin levels, and increase cardiac contractility, demonstrating their potential therapeutic benefits.

Career Highlights

John E Emma is affiliated with the American Cyanamid Company, where he has made significant strides in his research and development efforts. His work has not only advanced the understanding of triarylphosphinimide derivatives but has also contributed to the broader field of medicinal chemistry.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues, including Andrew S Tomcufcik and Nancy H Eudy. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

John E Emma's contributions to the field of chemistry, particularly in the development of triarylphosphinimide derivatives, highlight his role as a significant inventor. His work continues to influence advancements in medicinal applications, showcasing the importance of innovation in science.